Brief: Cidara Therapeutics To Expand And Accelerate Phase 3 Trial Of CD388
24/09/2025 12:09
Sept 24 (Reuters) - Cidara Therapeutics Inc CDTX.O: CIDARA THERAPEUTICS INC - TO EXPAND AND ACCELERATE PHASE 3 TRIAL OF CD388 Source text: ID:nGNX3pWwsH Further company coverage: CDTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cidara Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Merck Seeks Up To $8 Billion In Us Bond Sale Tied To Cidara Deal - Bloomberg News
Merck rises after Wells Fargo upgrades stock to 'overweight'
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade